tirzepatide and methylcobalamin Compounded versions of (Mounjaro, Zepbound) containing vitamin B12 pose a potential safety risk to the public, Eli Lilly warned in an open letter on Thursday. Following laboratory testing, the drugmaker said Preserving Muscle While Losing Fat:

The GROMACS program was used to assess the stability of the engineered fusion proteins, and the PyMOL package was used to visualize their structure

As of November 8, it has also been FDA-approved for weight loss, sold as Zepbound

If you suspect you've accidentally injected semaglutide into muscle: Do not administer an extra dose to compensate Continue your regular dosing schedule for future injections Monitor for unusual symptoms but understand that occasional technique errors are unlikely to significantly compromise overall treatment Pay attention to blood glucose levels , especially if you also take insulin or sulfonylureas, as these combinations increase hypoglycemia risk Contact your healthcare provider promptly if you experience: Severe or persistent abdominal pain (potential sign of pancreatitis) Signs of allergic reaction (rash, swelling, difficulty breathing) Symptoms of hypoglycemia (if on insulin or sulfonylureas) Signs of infection at the injection site While an occasional intramuscular injection is not typically a medical emergency, proper technique for future injections is important for consistent medication delivery and therapeutic effect

Tirzepatide is a once-weekly injectable medication approved by the FDA for the treatment of type 2 diabetes mellitus (marketed as Mounjaro) and chronic weight management (marketed as Zepbound)